Forschung

HNO-Tumoren

A randomized phase III trial comparing sequential therapy with TPF/chemoradiation (ST) to cisplatin-based chemoradiotherapy with accelerated concomitant boost radiotherapy (CRT) for locally advanced squamous cell cancer of the head and neck (The Paradigm Trial)

Prüfer: Prof. Dr. C. Rödel, PD Dr. M. Hambek (HNO)

Protocol Chairman:
Marshall R. Posner, MD
Dana Farber Cancer Insitute
Boston, MA, USA